|
Market Closed -
Canadian Securities Exchange
01:29:08 15/05/2026 am IST
|
5-day change
|
1st Jan Change
|
|
0.2950 CAD
|
0.00%
|
 |
-9.23%
|
+15.69%
|
|
15/05 |
Vext Engages Zuanic & Associates
|
NE
| |
15/05 |
Vext Announces Date for Q1 2026 Financial Results Release
|
NE
| |
29/04 |
Vext Science, Inc., Q4 2025 Earnings Call, Apr 29, 2026
| | |
29/04 |
Vext Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
29/04 |
Vext Science : Fourth Quarter 2025 Press Release
|
PU
| |
29/04 |
Vext Science : Fourth Quarter 2025 Financial Statements
|
PU
| |
29/04 |
Vext Science : Fourth Quarter 2025 MD&A
|
PU
| |
29/04 |
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
|
NE
| |
22/04 |
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
|
NE
| |
30/03 |
Vext Science, Inc. Announces Intention to Discontinue Operations At Its Cultivation Facility in Eloy Facility, Arizona
|
CI
| |
30/03 |
Vext Science, Inc. Intends to Seek Approval from State of Ohio to Expand its Cultivation Facility in Jackson
|
CI
| |
30/03 |
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
|
NE
| |
04/03 |
Vext Science, Inc. Expands With Seventh Dispensary In Ohio
|
CI
| |
04/03 |
Vext Advances Ohio Expansion with Seventh Retail Location
|
NE
| |
03/01 |
Early Warning News Release of Jason T. Nguyen
|
NE
| |
12/12 |
Vext Announces Voting Results of Annual General Meeting
|
NE
| |
21/11 |
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
|
NE
| |
20/11 |
Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
|
CI
| |
20/11 |
Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025
| | |
20/11 |
Vext Science, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025
|
CI
| |
20/11 |
Vext Science Reports Q3 Net Loss Of US$2.6 MILLION
|
MT
| |
20/11 |
Vext Science : Third Quarter 2025 Press Release
|
PU
| |
20/11 |
Vext Science : Third Quarter 2025 Financial Statements
|
PU
| |
20/11 |
Vext Science : Third Quarter 2025 MD&A
|
PU
| |
20/11 |
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
|
NE
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
